These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 18757456)

  • 1. Evaluation of serum CC-16 as a biomarker for COPD in the ECLIPSE cohort.
    Lomas DA; Silverman EK; Edwards LD; Miller BE; Coxson HO; Tal-Singer R;
    Thorax; 2008 Dec; 63(12):1058-63. PubMed ID: 18757456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased serum club cell secretory protein in asthma and chronic obstructive pulmonary disease overlap: a pilot study.
    Oh JY; Lee YS; Min KH; Hur GY; Lee SY; Kang KH; Rhee CK; Park SJ; Shim JJ
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3411-3417. PubMed ID: 30425470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study.
    Coxson HO; Dirksen A; Edwards LD; Yates JC; Agusti A; Bakke P; Calverley PM; Celli B; Crim C; Duvoix A; Fauerbach PN; Lomas DA; Macnee W; Mayer RJ; Miller BE; Müller NL; Rennard SI; Silverman EK; Tal-Singer R; Wouters EF; Vestbo J;
    Lancet Respir Med; 2013 Apr; 1(2):129-36. PubMed ID: 24429093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Club cell protein 16 and disease progression in chronic obstructive pulmonary disease.
    Park HY; Churg A; Wright JL; Li Y; Tam S; Man SF; Tashkin D; Wise RA; Connett JE; Sin DD
    Am J Respir Crit Care Med; 2013 Dec; 188(12):1413-9. PubMed ID: 24245748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum surfactant protein D is steroid sensitive and associated with exacerbations of COPD.
    Lomas DA; Silverman EK; Edwards LD; Locantore NW; Miller BE; Horstman DH; Tal-Singer R;
    Eur Respir J; 2009 Jul; 34(1):95-102. PubMed ID: 19164344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive characterisation of pulmonary and serum surfactant protein D in COPD.
    Winkler C; Atochina-Vasserman EN; Holz O; Beers MF; Erpenbeck VJ; Krug N; Roepcke S; Lauer G; Elmlinger M; Hohlfeld JM
    Respir Res; 2011 Mar; 12(1):29. PubMed ID: 21396106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clara cell 16 protein in COPD sputum: a marker of small airways damage?
    Braido F; Riccio AM; Guerra L; Gamalero C; Zolezzi A; Tarantini F; De Giovanni B; Folli C; Descalzi D; Canonica GW
    Respir Med; 2007 Oct; 101(10):2119-24. PubMed ID: 17624750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of serum CC16 levels with smoking status and lung function in COPD.
    Gribben KC; Poole JA; Nelson AJ; Farazi PA; Wichman CS; Heires AJ; Romberger DJ; LeVan TD
    Respir Res; 2022 Sep; 23(1):247. PubMed ID: 36114505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COPD association and repeatability of blood biomarkers in the ECLIPSE cohort.
    Dickens JA; Miller BE; Edwards LD; Silverman EK; Lomas DA; Tal-Singer R;
    Respir Res; 2011 Nov; 12(1):146. PubMed ID: 22054035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effect of club cell secretory protein (CC-16) on COPD risk and progression: a Mendelian randomisation study.
    Milne S; Li X; Hernandez Cordero AI; Yang CX; Cho MH; Beaty TH; Ruczinski I; Hansel NN; Bossé Y; Brandsma CA; Sin DD; Obeidat M
    Thorax; 2020 Nov; 75(11):934-943. PubMed ID: 32839289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced Serum Concentration of CC16 Is Associated with Severity of Chronic Obstructive Pulmonary Disease and Contributes to the Diagnosis and Assessment of the Disease.
    Rong B; Fu T; Gao W; Li M; Rong C; Liu W; Liu H
    Int J Chron Obstruct Pulmon Dis; 2020; 15():461-470. PubMed ID: 32184583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory and Bronchitic Symptoms Predict Intention to Quit Smoking among Current Smokers with, and at Risk for, Chronic Obstructive Pulmonary Disease.
    Melzer AC; Feemster LC; Crothers K; Carson SS; Gillespie SE; Henderson AG; Krishnan JA; Lindenauer PK; McBurnie MA; Mularski RA; Naureckas ET; Pickard AS; Au DH;
    Ann Am Thorac Soc; 2016 Sep; 13(9):1490-6. PubMed ID: 27268422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of surfactant protein A, surfactant protein D, Clara cell protein 16, S100 protein, trefoil factor 3, and prostatic secretory protein 94 in idiopathic pulmonary fibrosis, sarcoidosis, and chronic pulmonary obstructive disease.
    Doubková M; Karpíšek M; Mazoch J; Skřičková J; Doubek M
    Sarcoidosis Vasc Diffuse Lung Dis; 2016 Oct; 33(3):224-234. PubMed ID: 27758987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 and interleukin-8 blood levels' poor association with the severity and clinical profile of ex-smokers with COPD.
    de Moraes MR; da Costa AC; Corrêa Kde S; Junqueira-Kipnis AP; Rabahi MF
    Int J Chron Obstruct Pulmon Dis; 2014; 9():735-43. PubMed ID: 25114519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between serum biomarkers and BODE index in patients with stable COPD.
    Liu SF; Chin CH; Wang CC; Lin MC
    Respirology; 2009 Sep; 14(7):999-1004. PubMed ID: 19740260
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath condensate pH as a biomarker of COPD severity in ex-smokers.
    Papaioannou AI; Loukides S; Minas M; Kontogianni K; Bakakos P; Gourgoulianis KI; Alchanatis M; Papiris S; Kostikas K
    Respir Res; 2011 May; 12(1):67. PubMed ID: 21600044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and Radiologic Disease in Smokers With Normal Spirometry.
    Regan EA; Lynch DA; Curran-Everett D; Curtis JL; Austin JH; Grenier PA; Kauczor HU; Bailey WC; DeMeo DL; Casaburi RH; Friedman P; Van Beek EJ; Hokanson JE; Bowler RP; Beaty TH; Washko GR; Han MK; Kim V; Kim SS; Yagihashi K; Washington L; McEvoy CE; Tanner C; Mannino DM; Make BJ; Silverman EK; Crapo JD;
    JAMA Intern Med; 2015 Sep; 175(9):1539-49. PubMed ID: 26098755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study.
    de Torres JP; Casanova C; Pinto-Plata V; Varo N; Restituto P; Cordoba-Lanus E; Baz-Dávila R; Aguirre-Jaime A; Celli BR
    PLoS One; 2011 Jan; 6(1):e16021. PubMed ID: 21267454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterisation of COPD heterogeneity in the ECLIPSE cohort.
    Agusti A; Calverley PM; Celli B; Coxson HO; Edwards LD; Lomas DA; MacNee W; Miller BE; Rennard S; Silverman EK; Tal-Singer R; Wouters E; Yates JC; Vestbo J;
    Respir Res; 2010 Sep; 11(1):122. PubMed ID: 20831787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.